Blum Robert I Insider Trades & Stock Holdings

President & CEO · Cytokinetics, Incorporated · Latest filing Oct 12, 2026

Blum Robert I, President & CEO at Cytokinetics, Incorporated has 2 Form 4 trades on file since Sep 28, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($962.55K), net -$962.55K. Latest filing: disposed of 7.50K shares of $CYTK on Oct 12, 2026 at $62.88.

Trades on file

2

Open-market bought

$0

Open-market sold

$962.55K

Net open-market

-$962.55K

Latest filing

Oct 12, 2026

All insider trades by Blum Robert I

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 12, 2026	$CYTK	Sell (Open-market sale) 10b5-1	7.50K	$62.88	$471.60K						President & CEO		Read
Sep 28, 2026	$CYTK	Sell (Open-market sale) 10b5-1	7.50K	$65.46	$490.95K			-5.2%			President & CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Blum Robert I traded

• $CYTK

Frequently asked questions

Has Blum Robert I been buying or selling stock?

Blum Robert I has 0 open-market purchases and 2 open-market sales on file, net -$962.55K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Blum Robert I's latest insider trade?

disposed of 7.50K shares of $CYTK on Oct 12, 2026 at $62.88.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.